|  | Year 2013 | 2014 | 2015 | 2016 | Total |
---|---|---|---|---|---|---|
Ascertained cases | male | 14 | 13 | 18 | 15 | 60 |
female | 8 | 7 | 7 | 5 | 27 | |
total | 22 | 20 | 25 | 20 | 87 | |
N of children with ASD born in the catchment area | male | 8 | 9 | 14 | 13 | 44 |
female | 5 | 7 | 6 | 5 | 23 | |
total | 13 | 16 | 20 | 18 | 67 | |
A total N of 5-year-old children in the catchment area | male | 685 | 639 | 600 | 625 | 2549 |
female | 625 | 622 | 621 | 599 | 2467 | |
total | 1310 | 1261 | 1221 | 1224 | 5016 | |
N of 5-year-old whose caregivers returned the screening questionnaire | male | 506 | 496 | 489 | 531 | 2022 |
female | 449 | 468 | 515 | 500 | 1932 | |
total | 954 | 964 | 1004 | 1031 | 3954 | |
N of the birth cohort in the catchment area | male | 703 | 648 | 639 | 603 | 2593 |
female | 656 | 610 | 664 | 589 | 2519 | |
total | 1359 | 1258 | 1303 | 1192 | 5112 | |
Crude orevalence (%) (95% confidence interval: CI) | male | 2.04 (0.98–3.10) | 2.03 (0.94–3.13) | 3.00 (1.64–4.36) | 2.82 (1.42–4.23) | 2.35 (1.76–2.94) |
female | 1.28 (0.40–2.16) | 1.13 (0.30–1.95) | 1.13 (0.30–1.96) | 0.83 (0.11–1.56) | 1.09 (0.68–1.51) | |
total | 1.68 (0.98–2.38) | 1.59 (0.90–2.28) | 2.05 (1.25–2.84) | 1.63 (0.92–2.34) | 1.73 (1.37–2.10) | |
Adjusted prevalence (%) (95% CI) | male | – | – | – | – | 4.06 (3.20–4.92) |
female | – | – | – | – | 2.22 (1.57–2.88) | |
total | – | – | – | – | 3.22 (2.66–3.76) | |
Cumulative incidence up to 5 years of age (%) (95% CI) | male | 1.14 (0.35–1.92) | 1.39 (0.49–2.29) | 2.19 (1.06–3.33) | 2.16 (1.00–3.32) | 1.70 (1.20–2.19) |
female | 0.76 (0.10–1.43) | 1.15 (0.30–1.99) | 0.90 (0.18–1.62) | 0.85 (0.11–1.59) | 0.91 (0.54–1.28) | |
total | 0.96 (0.44–1.47) | 1.27 (0.65–1.89) | 1.53 (0.87–2.20) | 1.51 (0.82–2.20) | 1.31 (1.00–1.62) |